However, considering the further reduction of 24(S)-OHC in FXS individuals with full mutation as well as the role of FMRP in the regulation of expression of numerous brain proteins (51), we hypothesize that FMRP might control the expression and/or activity of CYP46A1. This evidence concerns the gene CYP46A1 and fragile X syndrome.